Erasca
Clinical-stage precision oncology company developing therapies that target the RAS/MAPK cancer signaling pathway
Highlights
- New on EvolcAdded 2026-11-11
About Erasca
Erasca is a clinical-stage precision oncology company developing therapies for RAS- and MAPK pathway-driven cancers. Its pipeline uses small molecules, large molecules and protein degraders, alone and in combination, across several tumor types.
The company develops drug candidates for cancer patients and is pursuing clinical development, regulatory approval and commercialization.
Erasca is headquartered in San Diego, California, at Merryfield Row. The website describes the company as co-founded in July 2018 by Jonathan E. Lim, M.D., who serves as Chairman and CEO. It is currently hiring for clinical development, regulatory affairs, regulatory operations and pharmaceutical development roles in San Diego, South San Francisco and remote.
Product: Investigational oncology therapies targeting the RAS/MAPK pathway, including the MAPKlamp strategy and RAS-directed agents, in clinical development.
Jobs at Erasca
More biotech & pharma companies
EVERY™
Animal-free egg white protein ingredients (OvoPro) made by precision fermentation for food manufacturers and foodserviceNew on EvolcFormation Bio
AI-driven pharmaceutical company acquiring and developing clinical-stage drugs to bring treatments to patients fasterNew on EvolcFractyl Health
Develops endoscopic and gene therapies that target root causes of obesity and type 2 diabetesNew on EvolcGatesfoundation
Non-profit developing drugs, biologics and vaccines for tuberculosis and malaria in low- and middle-income countriesGilead
Develops CAR T-cell therapies and other cell therapy treatments for people with cancerGilead
Biopharmaceutical company developing and delivering therapies for serious diseases, including virology, oncology and inflammation treatments
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- VueMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.